The Health Minister of New Zealand, David Cunliffe, has provided conditional approval to permit porcine cells to be transplanted into eight individuals with type 1 diabetes .
The treatments will form part of a clinical trial, conducted by Kiwi firm Living Cell Technologies. Living Cell Technologies are a pioneering company looking for ways to improve treatment for type 1 diabetics .
LCT are attempting a type of xenotransplantatio, injecting the pig cells into type 1 diabetes patients to try and produce insulin in the body, thereby reducing the need for insulin injections .
Cunliffe took considerable advice before making his decisio, and granted approval for the trial to go ahead at the Middle more Hospital in Auckland, subject to one further review.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…